Galectin Therapeutics Shares Are Trading Lower After the Company Announced Top-line Results of Its NAVIGATE Clinical Trial and Confirmed Belapectin Did Not Achieve Statistical Significance.
Galectin Therapeutics Shares Are Trading Lower After the Company Announced Top-line Results of Its NAVIGATE Clinical Trial and Confirmed Belapectin Did Not Achieve Statistical Significance.
Galectin Therapeutics的股票在公司宣布其NAVIGATE临床试验的主要结果并确认Belapectin未达到统计学显著性后下跌。
Galectin Therapeutics Shares Are Trading Lower After the Company Announced Top-line Results of Its NAVIGATE Clinical Trial and Confirmed Belapectin Did Not Achieve Statistical Significance.
Galectin Therapeutics的股价走低，此前该公司公布了其NAVIGATE临床试验的最终结果，并确认Belapectin没有达到统计学意义。
资讯热榜
更新时间